LEVI HONGSERMEIER: Open Payments
NPI 1700461639 · REDDING, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,715 in 128 payments from 13 companies in 2025. Trend: 2023 $2,735 · 2024 $2,512 · 2025 $2,715
Food & beverage: $2,715
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $565 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 30 | $527 |
| Neurocrine BioSciences, Inc. | 14 | $488 |
| Janssen Pharmaceuticals, Inc | 14 | $303 |
| Axsome Therapeutics, Inc. | 14 | $207 |
| Otsuka America Pharmaceutical, Inc. | 8 | $169 |
| Vanda Pharmaceuticals Inc. | 11 | $137 |
| Teva Pharmaceuticals USA, Inc. | 4 | $98 |
| E.R. Squibb & Sons, L.L.C. | 3 | $66 |
| Collegium Pharmaceutical, Inc. | 4 | $63 |
Products named: VRAYLAR, CAPLYTA, INGREZZA, SPRAVATO, Auvelity, REXULTI, FANAPT, COBENFY.
Industry payments across CA — which companies pay providers there.
